Greene Barry E
CIK: 0001291963•President and CEO
OfficerDirector
Primary company: ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greene Barry E is a corporate insider (President and CEO) at ALNYLAM PHARMACEUTICALS, INC. (ALNY) filing SEC Form 4 transactions. 300 transactions across 5 companies, totaling $2,153,476 in purchases and $61,324,922 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 57,463 | $20.87 | $1.20M | 57,463 | 6/22/2026 Filed: 6/22/2026 | Filing → | |
| Award | 15,508 | - | - | 16,415 | 5/21/2026 Filed: 5/21/2026 | Filing → | |
Sage Therapeutics, Inc. SAGE | Disposition | 174,000 | - | - | 0 | 7/31/2025 Filed: 7/31/2025 | Filing → |
Sage Therapeutics, Inc. SAGE | Disposition | 53,229 | - | - | 0 | 7/31/2025 Filed: 7/31/2025 | Filing → |
Sage Therapeutics, Inc. SAGE | U | 46,940 | - | - | 0 | 7/31/2025 Filed: 7/31/2025 | Filing → |
| Award | 4,600 | - | - | 4,600 | 5/28/2025 Filed: 5/29/2025 | Filing → | |
Sage Therapeutics, Inc. SAGE | Tax Payment | 4,862 | $6.91 | $34K | 100,169 | 4/10/2025 Filed: 4/11/2025 | Filing → |
Sage Therapeutics, Inc. SAGE | Award | 19,964 | - | - | 105,031 | 4/10/2025 Filed: 4/11/2025 | Filing → |
Sage Therapeutics, Inc. SAGE | Award | 174,000 | $6.97 | $1.21M | 174,000 | 1/16/2025 Filed: 1/21/2025 | Filing → |
Sage Therapeutics, Inc. SAGE | Tax Payment | 12,273 | $8.96 | $110K | 85,067 | 8/5/2024 Filed: 8/7/2024 | Filing → |
Sage Therapeutics, Inc. SAGE | Award | 50,400 | - | - | 97,340 | 8/5/2024 Filed: 8/7/2024 | Filing → |
| Award | 69,000 | - | - | 69,000 | 5/29/2024 Filed: 5/30/2024 | Filing → | |
Sage Therapeutics, Inc. SAGE | Award | 168,000 | - | - | 168,000 | 2/13/2024 Filed: 2/15/2024 | Filing → |
Sage Therapeutics, Inc. SAGE | Award | 195,000 | $0.00 | $0 | 195,000 | 8/4/2023 Filed: 8/8/2023 | Filing → |
| Award | 34,000 | $0.00 | $0 | 34,000 | 5/24/2023 Filed: 5/25/2023 | Filing → | |
Sage Therapeutics, Inc. SAGE | Award | 66,500 | $0.00 | $0 | 66,500 | 2/13/2023 Filed: 2/15/2023 | Filing → |
Sage Therapeutics, Inc. SAGE | Purchase | 14,500 | $34.48 | $500K | 46,940 | 11/10/2022 Filed: 11/15/2022 | Filing → |
| Exercise | 7,576 | $0.00 | $0 | 0 | 8/11/2022 Filed: 8/15/2022 | Filing → | |
| Exercise | 7,576 | $1.49 | $11K | 13,606 | 8/11/2022 Filed: 8/15/2022 | Filing → | |
| Award | 23,900 | $0.00 | $0 | 23,900 | 5/19/2022 Filed: 5/20/2022 | Filing → |
Type
Award
Shares
57,463
Price
$20.87
Value
$1.20M
Type
Award
Shares
15,508
Price
-
Value
-
Sage Therapeutics, Inc.
SAGE
Type
Disposition
Shares
174,000
Price
-
Value
-
Sage Therapeutics, Inc.
SAGE
Type
Disposition
Shares
53,229
Price
-
Value
-
Sage Therapeutics, Inc.
SAGE
Type
U
Shares
46,940
Price
-
Value
-
Type
Award
Shares
4,600
Price
-
Value
-
Sage Therapeutics, Inc.
SAGE
Type
Tax Payment
Shares
4,862
Price
$6.91
Value
$34K
Sage Therapeutics, Inc.
SAGE
Type
Award
Shares
19,964
Price
-
Value
-
Sage Therapeutics, Inc.
SAGE
Type
Award
Shares
174,000
Price
$6.97
Value
$1.21M
Sage Therapeutics, Inc.
SAGE
Type
Tax Payment
Shares
12,273
Price
$8.96
Value
$110K
Sage Therapeutics, Inc.
SAGE
Type
Award
Shares
50,400
Price
-
Value
-
Type
Award
Shares
69,000
Price
-
Value
-
Sage Therapeutics, Inc.
SAGE
Type
Award
Shares
168,000
Price
-
Value
-
Sage Therapeutics, Inc.
SAGE
Type
Award
Shares
195,000
Price
$0.00
Value
$0
Type
Award
Shares
34,000
Price
$0.00
Value
$0
Sage Therapeutics, Inc.
SAGE
Type
Award
Shares
66,500
Price
$0.00
Value
$0
Sage Therapeutics, Inc.
SAGE
Type
Purchase
Shares
14,500
Price
$34.48
Value
$500K
Type
Exercise
Shares
7,576
Price
$0.00
Value
$0
Type
Exercise
Shares
7,576
Price
$1.49
Value
$11K
Type
Award
Shares
23,900
Price
$0.00
Value
$0
AI Agent
Try asking...